Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2005
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1301207B1 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
08/10/2005EP1292317B1 Hypotensive and hypertensive properties of renomedullar extracts
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1169441B8 Pharmaceutical compositions for the treatment of heart failure
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005EP1009447B1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof
08/10/2005CN1653083A Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1653075A C-aryl glucoside SGLT2 inhibitors and method
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1652839A System and method for treating cardiac arrhythmias with fibroblast cells
08/10/2005CN1652831A Electrocardiographic aspects of CHF treatment
08/10/2005CN1652812A Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
08/10/2005CN1652811A A combination product comprising melagatran and an anti-arrhythmic oxabispidenes
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652785A Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652778A Method for treating obesity
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652774A Use of valsartan or its metabolite to inhibit platelet aggregation
08/10/2005CN1652773A Substantially pure solid form of the enol tautomer of 3-indolylpyruvic acid for use in the treatment of central nervous system disturbances
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1652757A Use of EDG receptor binding agents in cancer
08/10/2005CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements
08/10/2005CN1651470A Low molecular weight heparin triethanolamine salt usable as local delivery antithrombotic treating agent, preparing process and use thereof
08/10/2005CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion
08/10/2005CN1651420A Dehydro methyl abietate furazan derivative, its synthesis method and use
08/10/2005CN1651087A Combination of organic compounds
08/10/2005CN1651086A Compound red yeast extract medicinal preparation and its application
08/10/2005CN1651085A Compound aspirin tading kind medicinal preparation and its application
08/10/2005CN1651075A Therapeutic application of cone shell toxin SO3
08/10/2005CN1651067A Medicinal composition for treating and/or preventing heart brnin blood vessel disease and its preparation method
08/10/2005CN1651057A Cinnamon poria capsule and its preparation process
08/10/2005CN1651056A Cinnamon poria capsule and its preparation process
08/10/2005CN1651029A Medicinal composition possessing synergistic action
08/10/2005CN1651028A Medicinal composition having synergistic action
08/10/2005CN1651027A Medicinal composition having synergistic action
08/10/2005CN1651026A Injection liquid for treating heart brain blood vessel disease and its prearation method
08/10/2005CN1651024A Salvia root capsule and its preparation technology
08/10/2005CN1651009A Health care food for preventing and treating heart brain blood vessel disease and its preparation method
08/10/2005CN1651007A Ginkgo ketone ester drop pill and its preparation method
08/10/2005CN1651003A Medicinal composition for treating heart brain blood vessel disease and its preparation method
08/10/2005CN1650999A Musk heart protecting oral cavity disintegrating tablet and its preparation method
08/10/2005CN1650988A Chinese medicinal preparation for treating heart brain blood vessel diseases and its preparation method
08/10/2005CN1650981A Compound red leaven extract medicinal preparation and its application
08/10/2005CN1650979A Chinese herbal medicine for treating high blood pressure and its preparation process
08/10/2005CN1650978A Application of ligusticum oil in preparation of medicine for treating cerebral thrombosis
08/10/2005CN1650972A Glow release micro pill containing gingko leaf extract and its preparation method
08/10/2005CN1650970A Chinese medicinal preparation for treating heart brain blood vessel disease and its preparation method
08/10/2005CN1650969A Compound gingko leaf hawthorn medicinal preparation and its making method
08/10/2005CN1650965A Toosendan dipyridamole medicinal preparation and its preparation method
08/10/2005CN1650964A Compound gingko leaf astruganus root medicinal preparation and its preparation method
08/10/2005CN1650962A Chinese medicinal preparation for treating arrhythmia and its preparation method
08/10/2005CN1650947A Composition of gingko leaf extract
08/10/2005CN1650943A Medicine for treating high blood pressure disease
08/10/2005CN1650939A Health care tea for preventing cancer, lowering blood fat and lowering blood pressure
08/10/2005CN1650927A Medicine containing ketone effective component
08/10/2005CN1650921A Health care medicinal pillow
08/10/2005CN1650919A Prescription of Chinese medicine compound preparation, its preparation method and use
08/10/2005CN1650917A Medicine for treating arrhythmia and its preparation method
08/10/2005CN1650911A Compound gingko chewing gun, lozenge, chewing tablet and its manufacutring method
08/10/2005CN1650908A Method of extracting total flavone product from halenalin plant full flower
08/10/2005CN1650907A Zhogkang pill
08/10/2005CN1650901A Method of extracting raw medicament for improving acute cardiomyopathy insufficient blood supply antianoxia from pure Chinese medical preparation
08/10/2005CN1650891A Medicinal composition posssessing synergistic action
08/10/2005CN1650885A Hydroxy ethyl starch for injection and its preparation method
08/10/2005CN1650882A Medical and health care use of adenyl and guanyl kind compound and medicine or health protection product for reducing blood pressure and improving cardio and vascular function
08/10/2005CN1650881A Erigeron breviscapus medicinal preparation and its preparation method
08/10/2005CN1650875A Use of 3, 4, 5-trihydroxy stilbene-3-beta-D-gluooside in preparation of antimyocardial ischemia medicine
08/10/2005CN1650871A Sodium fructose diphosphate granule agent and its preparation method
08/10/2005CN1650859A Enapoli maleate dispersion tablet and its preparation technology
08/10/2005CN1650850A Ibolite fumarate nasal cavity administration preparation
08/10/2005CN1650849A Bisolol non intestine medicinal preparation
08/10/2005CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof
08/10/2005CN1214031C Hydropyridine deriv. acid addition salts
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214025C Sodium channel modulators derived from 2-piperidylimidazoles
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
1 ... 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 ... 1595